Related Experiment Video
Updated: Jun 8, 2026
08:41
Modeling Chemotherapy Resistant Leukemia In Vitro
Published on: February 9, 2016
Multi-objective optimal chemotherapy control model for cancer treatment
S Algoul1, M S Alam, M A Hossain
1Department of Computing, University of Bradford, Bradford, UK. S.K.A.Algoul@Bradford.ac.uk
Medical & Biological Engineering & Computing
|October 2, 2010
Summary
This study introduces a novel optimal chemotherapy control model using PID/IPD controllers to minimize cancer cells and side effects. The multi-objective genetic algorithm optimizes treatment for maximum tumor cell killing and minimum toxicity.
Area of Science:
- Biomedical Engineering
- Mathematical Oncology
- Control Systems
Background:
- Mathematical models are crucial for predicting tumor cell dynamics and guiding chemotherapy.
- Understanding cancer system dynamics and treatment effects is essential for effective chemotherapy control.
Purpose of the Study:
- To develop a multi-objective optimal chemotherapy control model.
- To reduce cancer cells post-treatment with minimal side effects.
- To optimize drug concentration for efficacy and safety.
Main Methods:
- Utilized proportional, integral, and derivative (PID) and I-PD controllers.
- Employed Martin's model for drug concentration dynamics.
- Applied a multi-objective genetic algorithm (MOGA) for parameter optimization.
Main Results:
- The proposed PID/IPD-based model effectively balances maximizing tumor cell killing, minimizing toxicity, and maintaining tolerable drug concentrations.
- Optimal scheduling patterns were identified through experimental validation.
- The developed model demonstrated superior performance compared to existing chemotherapy models.
Conclusions:
- The novel multi-objective optimal chemotherapy control model offers a promising approach for cancer treatment.
- This research represents the first application of PID/IPD controllers in an optimal chemotherapy control framework.
- The MOGA-tuned controllers provide a robust trade-off between therapeutic efficacy and patient safety.
Related Concept Videos
01:21Cancer Survival Analysis
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...